awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33747261-0C36FA85-7D4A-46AD-B32F-A820587836B8
Q33747261-0C36FA85-7D4A-46AD-B32F-A820587836B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33747261-0C36FA85-7D4A-46AD-B32F-A820587836B8
Imatinib: a breakthrough of targeted therapy in cancer.
P2860
Q33747261-0C36FA85-7D4A-46AD-B32F-A820587836B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33747261-0C36FA85-7D4A-46AD-B32F-A820587836B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869f185b111d7374dca012adf181cbc1ce7fa6ae
P2860
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.